Showing In the Press
Texas Oncology’s Dr. Debra Patt weighed in with Fierce Healthcare on where the oncology ecosystem stands on the Trump administration’s most-favored-nation final rule
Texas Oncology’s Dr. Debra Patt weighed in with Fierce Healthcare on where the oncology ecosystem stands on the Trump administration’s most-favored-nation final rule Read the full article here.
Read more
ADVI Health estimates year one of the Most Favored Nations (MFN) Model could cut Part B drug payments by $4.2 Billion.
ADVI Health estimates year one of the Most Favored Nations (MFN) Model could cut Part B drug payments by $4.2 Billion.
Read more
Lindsay Bealor Greenleaf discusses the health care policy outlook under a likely split Congress and Biden Administration with Morning Consult
Lindsay Bealor Greenleaf discusses the health care policy outlook under a likely split Congress and Biden Administration with Morning Consult
Read more
ADVI VP Lindsay Bealor Greenleaf explained to Fierce Healthcare about drug policy expectations following the Presidential election
“This focus on how things are paid for abroad is a general theme across both administrations,” ADVI VP Lindsay Bealor Greenleaf explained to
Fierce Healthcare about drug policy expectations following the Presidential election.